January/February 2026 Supplement
The Importance of Clinical Decision in an Evolving Treatment Landscape
PHYSICIAN CHOICE: A Critical Aspect of Treating Patients with Retinal Disease
Philip I. Niles MD, MBA, and David R.P. Almeida, MD, MBA, PhD
November/December 2025 | Global Perspectives
The Need for Novel Intraocular Tamponade Agents
Surgical, diagnostic, and environmental considerations of standard tamponades reveal the potential benefits of a better solution.
Mario Romano, MD, PhD; Robert L. Avery, MD; David A. Eichenbaum, MD; and Anat Loewenstein, MD
October 2025 Supplement
GA Options in Clinical Therapy: Keeping Patients at the Center of GA Therapy
John W. Kitchens, MD; Ferhina S. Ali, MD, MPH; Margaret Chang, MD, MS; and David A. Eichenbaum, MD
September 2025 Insert
One To Watch: Priya Vakharia, MD, FASRS
Priya Vakharia, MD, FASRS
April 2025 | Meeting Minutes
Key Lectures From Angiogenesis 2025
A look at top presentations and discussions ranging from imaging and therapy to the latest clinical trial data.
Catherine Manthorp, BA, Senior Editor; Alex Brodin, MA, Senior Editor; and Rebecca Hepp, MA, Editor-in-Chief
January/February 2025 | Features
Novel Surgical Techniques to Master
An overview of ports, implants, and gene therapy making their way into your surgical toolkit.
David A. Eichenbaum, MD, and Albert J. Augustin, MD
May/June 2023 | Features
A Look at Novel Geographic Atrophy Biomarkers
Multimodal imaging is now the standard for diagnosing dry AMD—here’s what you need to know.
Farhan E. Hiya, MD; Abrahim Ahmed, BS; and David A. Eichenbaum, MD
May/June 2022 Insert
Shifting the Paradigm
What topical approach could mean for early treatment of diabetic retinopathy.
Carl D. Regillo, MD; David J. Tanzer, MD; and Kerrie Brady, BPharm, MS, MBA
April 2022 | Meeting Minutes
Hot Topics at Angiogenesis 2022
Leaders in the field shared their thoughts on new imaging capabilities, the hope for a dry AMD therapy, and how to implement new treatments into practice.
Rebecca Hepp, Editor-in-Chief
October 2021 | Features
Management of Chronic Postoperative CME With Uveitis
Sustained-release implants should be considered for patients with chronic CME.
David A. Eichenbaum, MD
October 2021 | Medical Editors' Page
Breaks, Tears, and Holes, Oh My!
Allen C. Ho, MD, and Robert L. Avery, MD
September 2020 | Features
A Review of Clinical Trial Data for DME: BOULEVARD and MEAD
Dissecting the data from two studies provides perspective on the interaction of therapies with this disease.
Christopher Barron, MD, and David A. Eichenbaum, MD
May/June 2020 | Features
Curbing Our Enthusiasm for Telemedicine and Deciding on Treatments During COVID-19
COVID-19 has changed the way we think about telemedicine and treatment decisions. Is retina ready for telemedicine? How much have treatment decisions actually changed?
David A. Eichenbaum, MD
January/February 2020 | Features
Surgical Pearls for the EVA Platform
Improved fluidics and illumination are features of this vitrectomy system.
Ashley M. Crane, MD, and David A. Eichenbaum, MD
January/February 2020 | Medical Editors' Page
Tricks of the Trade
Allen C. Ho, MD, and Robert L. Avery, MD
October 2019 | Special Report
My Switch to New Needles for Intravitreal Injection
How one small instrument change improved my patients' lives.
David A. Eichenbaum, MD
July 2019 | Retinal Disease Awareness News
Lean Management Principles
Thinking About Efficiency in Clinical Operations
David A. Eichenbaum, MD, and Dennis Han, MD
July 2018 | Retinal Disease Awareness News
Working With the Referral Network
David A. Eichenbaum, MD; Derek Kunimoto, MD, JD; Mona A. Henri, OD; and Kaitlyn Rothberg, OD
